Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study
Titel:
Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study
Auteur:
Dummer, Reinhard Queirolo, Paola Gerard Duhard, Pauline Hu, Youyou Wang, Dao de Azevedo, Sergio Jobim Robert, Caroline Ascierto, Paolo Antonio Chiarion-Sileni, Vanna Pronzato, Paolo Spagnolo, Francesco Mujika Eizmendi, Karmele Liszkay, Gabriella de la Cruz Merino, Luis Tawbi, Hussein